CF PHARMTECH purchased 43,000 shares, spending 1.4565 million Hong Kong dollars on December 31st.
Changfeng Pharmaceutical (02652) announced that it will spend HK$1.4565 million to repurchase 43,000 shares on December 31, 2025.
CF PHARMTECH (02652) announced that they will spend 1.4565 million Hong Kong dollars to repurchase 43,000 shares on December 31, 2025.
Related Articles
LUYE PHARMA(02186): Xia Lian appointed as member of the nominating committee.
Shandong Molong Petroleum Machinery (00568) recently received a government subsidy of 20 million yuan.
HKET HOLDINGS (00423): Lou Chi-ming and Xu Xiaoqi have been appointed as executive directors.
LUYE PHARMA(02186): Xia Lian appointed as member of the nominating committee.
Shandong Molong Petroleum Machinery (00568) recently received a government subsidy of 20 million yuan.
HKET HOLDINGS (00423): Lou Chi-ming and Xu Xiaoqi have been appointed as executive directors.
